• jump to the main content
  • jump to the bottom of the page
  • News
  • Podcasts
  • Activities
  • Location and contact
  • Español Contenido en español
  • Català Contingut en català
  • English Current language Spanish
COLLABORATE El Meu Clínic . This link opens in a new tab.
  • Español Contenido en español
  • Català Contingut en català
  • English Current language Spanish
Idibaps logo
Search
COLLABORATE El Meu Clínic . This link opens in a new tab.
  • Healthcare
    • Diseases, symptoms and health conditions
    • Tests and procedures
    • Be healthy
    • Urgencies
    • Patients and companions
    • Assistive Devices
    • Organizational structure
  • Research
    • Home
    • About research
    • Areas and Programmes
    • Core Facilities
    • Knowledge and Technology Transfer
    • Work at Idibaps
  • Teaching
    • Teaching
    • Students
    • Residents
    • Training stays
    • Training for professionals
  • Patients and companions
  • About the Clinic
  • News
  • Podcasts
  • Activities
  • Location and contact
  • Español Contenido en español
  • Català Contingut en català
  • English Current language Spanish
COLLABORATE El Meu Clínic . This link opens in a new tab.
  • Español Contenido en español
  • Català Contingut en català
  • English Current language Spanish
Navigation thread
  • Home
  • Organizational structure
  • Unit of Breast Cancer
  • News
  • Unit of Breast Cancer

Unit News from Breast Cancer

Clínic Barcelona
Clínic Barcelona
November 8 2022 2024-04-26

What is the difference between a mammogram and a breast ultrasound?

Both imaging techniques detect breast lesions, but have differences between them.

Clínic Barcelona
Clínic Barcelona
September 22 2022 2022-09-22

The Hospital Clínic starts an immunotherapy trial based on tumour-infiltrating lymphocytes (TILs) in triple-negative breast cancer

Trial TILs001, which is open to patients with metastatic triple-negative breast cancer, is the first study to assess the safety and efficacy of TILs1

Clínic Barcelona
Clínic Barcelona
June 5 2022 2022-06-07

A new treatment is effective for advanced HER2-low breast cancer

Treatment with trastuzumab deruxtecan, a combination of a targeted therapy with chemotherapy, increases progression-free survival of the disease and1

Clínic Barcelona
Clínic Barcelona
January 25 2022 2022-01-25

Developed the first genomic test for personalized HER2+ breast cancer treatments

The new test, called HER2DX, analyzes RNA on 27 genes to predict survival outcomes and the likelihood that patients will respond to treatment.

Clínic Barcelona
Clínic Barcelona
March 29 2021 2021-03-29

A molecular classification predicts the prognosis and the benefit of a cell cycle inhibitor in metastatic breast cancer

In a study published in the Journal of Clinical Oncology, researchers from the Hospital Clínic-IDIBAPS-UB and SOLTI showed the predictive capacity of1

navigation between pages below

previous page
current page 2 / de 2
  • page1
  • page2 , current page.

Subscribe to the Newsletter of Clínic

Receive the latest news from our institution directly to your email.

Thanks for your subscription!

We have received your information. Check your inbox, in a few moments you will receive a confirmation email.

An error has occurred and we have not been able to send your data, please try again later.
  • Healthcare
    Healthcare
    • Diseases, symptoms and health conditions
    • Tests and procedures
    • Be healthy
    • Urgencies
    • Patients and companions
    • Work with Clínic
  • Research
    Research
    • Home
    • About research
    • Areas and Programmes
    • Core Facilities
    • Work with IDIBAPS
  • Teaching
    Teaching
    • Teaching
    • Students
    • Residents
    • Training stays
    • Training for professionals
  • Cookies policy
  • Profile of the contracting party
  • Legal Notice
  • Data protection
  • Transparency portal
  • Privacy policy
  • Complaint channel
  • Español Contenido en español
  • Català Contingut en català
  • English Current language Spanish
© Clínic Barcelona 2025